Gland Pharma plunges 13%, hits 52-week low on disappointing Q2 results ...Middle East

Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin contracted 150 bps to 33 per cent from 38 per cent in a year ago quarter.

Hence then, the article about gland pharma plunges 13 hits 52 week low on disappointing q2 results was published today ( Thursday 27/10/2022 - 07:44 AM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Gland Pharma plunges 13%, hits 52-week low on disappointing Q2 results )

Also on site :

• 2000s Heavy Metal Band Shares Exciting Music Festival News
• Saudi to Sudan: Can Pakistan expand military footprint across Arab world?
• Iconic '80s Heavy Metal Band Announces 2026 North America Tour Dates